Frontiers in Oncology | Thoracic Oncology

Systematic Review

Published on 29 Apr 2021

Driver Genes Associated With the Incidence of Venous Thromboembolism in Patients With Non-Small-Cell Lung Cancer: A Systematic Review and Meta-Analysis

in Thoracic Oncology

Xiaohan Qian
Mengjiao Fu
Jing Zheng
Jianya Zhou
Jianying Zhou

Frontiers in Oncology

doi 10.3389/fonc.2021.680191

5,766 views
23 citations

Original Research

Published on 28 Apr 2021

Identification of an Individualized Metabolism Prognostic Signature and Related Therapy Regimens in Early Stage Lung Adenocarcinoma

in Thoracic Oncology

Junjie Hu
Huansha Yu
Liangdong Sun
Yilv Yan
Lele Zhang
Gening Jiang
Peng Zhang

Frontiers in Oncology

doi 10.3389/fonc.2021.650853

3,710 views
9 citations

Original Research

Published on 28 Apr 2021

Pleural Fluid Has Pro-Growth Biological Properties Which Enable Cancer Cell Proliferation

in Thoracic Oncology

Rachelle Asciak
Nikolaos I. Kanellakis
Xuan Yao
Megat Abd Hamid
Rachel M. Mercer
Maged Hassan
Eihab O. Bedawi
Melissa Dobson
Peter Fsadni
Stephen Montefort

Frontiers in Oncology

doi 10.3389/fonc.2021.658395

5,243 views
21 citations

Original Research

Published on 27 Apr 2021

Characteristics of Ground-Glass Nodules Detected by Low-Dose Computed Tomography as a Regular Health Examination Among Chinese Hospital Employees and Their Parents

in Thoracic Oncology

Bihan Ouyang
Maoyuan Li
Li Li
Shaohui Liu
Min Li

Frontiers in Oncology

doi 10.3389/fonc.2021.661067

4,782 views
5 citations

Original Research

Published on 27 Apr 2021

Cost-Effectiveness Analysis of Atezolizumab Versus Chemotherapy as First-Line Treatment for Metastatic Non-Small-Cell Lung Cancer With Different PD-L1 Expression Status

in Thoracic Oncology

Guoqiang Liu
Shuo Kang
Xinchen Wang
Fangjian Shang

Frontiers in Oncology

doi 10.3389/fonc.2021.669195

8,265 views
33 citations

Original Research

Published on 27 Apr 2021

Comparison of Perioperative Outcomes Between Precise and Routine Segmentectomy for Patients With Early-Stage Lung Cancer Presenting as Ground-Glass Opacities: A Propensity Score-Matched Study

in Thoracic Oncology

Xianning Wu
Tian Li
Chuankai Zhang
Gao Wu
Ran Xiong
Meiqing Xu
Dan Su
Mingran Xie

Frontiers in Oncology

doi 10.3389/fonc.2021.661821

3,833 views
17 citations

Original Research

Published on 26 Apr 2021

Immune Checkpoint Blockade Therapy May Be a Feasible Option for Primary Pulmonary Lymphoepithelioma-like Carcinoma

in Thoracic Oncology

Zuohong Wu
Xinghong Xian
Ke Wang
Deyun Cheng
Weimin Li
Bojiang Chen

Frontiers in Oncology

doi 10.3389/fonc.2021.626566

5,142 views
26 citations

Original Research

Published on 26 Apr 2021

Identification of Resectable N2 in NSCLC: A Single Center Experience and Review of the SEER Database

in Thoracic Oncology

Yan-qing Wang
Xu-dong Liu
Wen-liang Bai
Shan-qing Li

Frontiers in Oncology

doi 10.3389/fonc.2021.647546

6,328 views
10 citations

Case Report

Published on 26 Apr 2021

Small Cell Lung Cancer Transformation as a Resistance Mechanism to Osimertinib in Epidermal Growth Factor Receptor-Mutated Lung Adenocarcinoma: Case Report and Literature Review

in Thoracic Oncology

Alessandro Leonetti
Roberta Minari
Giulia Mazzaschi
Letizia Gnetti
Silvia La Monica
Roberta Alfieri
Nicoletta Campanini
Michela Verzè
Andrea Olivani
Luigi Ventura

Frontiers in Oncology

doi 10.3389/fonc.2021.642190

11,436 views
42 citations

Original Research

Published on 26 Apr 2021

Identifying Genomic Alterations in Small Cell Lung Cancer Using the Liquid Biopsy of Bronchial Washing Fluid

in Thoracic Oncology

Jinfang Zhai
Songyan Han
Qinxiang Guo
Binbin Shan
Jing Wang
Yanrong Guo
Guoping Tong
Chang Zhao
Yuan Li
Qiao Han

Frontiers in Oncology

doi 10.3389/fonc.2021.647216

4,294 views
7 citations

Original Research

Published on 23 Apr 2021

Combined Analysis of RNA Sequence and Microarray Data Reveals a Competing Endogenous RNA Network as Novel Prognostic Markers in Malignant Pleural Mesothelioma

in Thoracic Oncology

Weicheng Duan
Kang Wang
Yijie Duan
Xiuyi Chen
Xufeng Chu
Ping Hu
Bo Xiong

Frontiers in Oncology

doi 10.3389/fonc.2021.615234

4,894 views
8 citations

Original Research

Published on 22 Apr 2021

Nivolumab and Hypofractionated Radiotherapy in Patients With Advanced Lung Cancer: ABSCOPAL-1 Clinical Trial

in Thoracic Oncology

Hua Ye
Haowen Pang
Xiangxiang Shi
Peirong Ren
Shangke Huang
Hong Yu
Jingbo Wu
Sheng Lin

Frontiers in Oncology

doi 10.3389/fonc.2021.657024

4,734 views
24 citations

Review

Published on 22 Apr 2021

Molecular Pathology of Pulmonary Large Cell Neuroendocrine Carcinoma: Novel Concepts and Treatments

in Thoracic Oncology

Masayo Yoshimura
Kurumi Seki
Andrey Bychkov
Junya Fukuoka

Frontiers in Oncology

doi 10.3389/fonc.2021.671799

11,420 views
17 citations

General Commentary

Published on 22 Apr 2021

Commentary: Overall Survival in Heart Disease–Related Death in Non-Small Cell Lung Cancer Patients: Nonimmunotherapy Versus Immunotherapy Era: Population-Based Study

in Thoracic Oncology

Yiping Jiao
Chengqi Qian
Shumin Fei

Frontiers in Oncology

doi 10.3389/fonc.2021.639042

2,167 views
1 citation

Original Research

Published on 22 Apr 2021

An Immune-Related lncRNA Expression Profile to Improve Prognosis Prediction for Lung Adenocarcinoma: From Bioinformatics to Clinical Word

in Thoracic Oncology

Boxiang Zhang
Rui Wang
Kai Li
Ziyang Peng
Dapeng Liu
Yunfeng Zhang
Liuzhi Zhou

Frontiers in Oncology

doi 10.3389/fonc.2021.671341

4,322 views
13 citations

Original Research

Published on 21 Apr 2021

Development and Validation a Nomogram Incorporating CT Radiomics Signatures and Radiological Features for Differentiating Invasive Adenocarcinoma From Adenocarcinoma In Situ and Minimally Invasive Adenocarcinoma Presenting as Ground-Glass Nodules Measuring 5-10mm in Diameter

in Thoracic Oncology

Lili Shi
Weiya Shi
Xueqing Peng
Yi Zhan
Linxiao Zhou
Yunpeng Wang
Mingxiang Feng
Jinli Zhao
Fei Shan
Lei Liu

Frontiers in Oncology

doi 10.3389/fonc.2021.618677

6,032 views
28 citations

Review

Published on 21 Apr 2021

Circulating Biomarkers for Early Stage Non-Small Cell Lung Carcinoma Detection: Supplementation to Low‐Dose Computed Tomography

in Thoracic Oncology

Chin Fung Kelvin Kan
Graham D. Unis
Luke Z. Li
Susan Gunn
Li Li
H. Peter Soyer
Mitchell S. Stark

Frontiers in Oncology

doi 10.3389/fonc.2021.555331

9,588 views
26 citations

Original Research

Published on 20 Apr 2021

Efficacy, Safety, and Cost-Minimization Analysis of Continuous Infusion of Low-Dose Gemcitabine Plus Cisplatin in Patients With Unresectable Malignant Pleural Mesothelioma

in Thoracic Oncology

Oscar Arrieta
Wendy Muñoz-Montaño
Sae Muñiz-Hernández
Saul Campos
Rodrigo Catalán
Herman Soto-Molina
Silvia Guzmán Vázquez
Osvaldo Díaz-Álvarez
Victor Martínez-Pacheco
Jenny G. Turcott

Frontiers in Oncology

doi 10.3389/fonc.2021.641975

6,930 views
5 citations

Original Research

Published on 20 Apr 2021

Feasibility and Challenges for Sequential Treatments in ALK-Rearranged Non-Small-Cell Lung Cancer

in Thoracic Oncology

Mei Elsayed
Farastuk Bozorgmehr
Daniel Kazdal
Anna-Lena Volckmar
Holger Sültmann
Jürgen R. Fischer
Mark Kriegsmann
Albrecht Stenzinger
Michael Thomas
Petros Christopoulos

Frontiers in Oncology

doi 10.3389/fonc.2021.670483

6,091 views
17 citations

Original Research

Published on 20 Apr 2021

Efficacy of Combination Chemo-Immunotherapy as a First-Line Treatment for Advanced Non-Small-Cell Lung Cancer Patients With HER2 Alterations: A Case Series

in Thoracic Oncology

Shuang Zhao
Xinghong Xian
Panwen Tian
Weimin Li
Ke Wang
Yalun Li

Frontiers in Oncology

doi 10.3389/fonc.2021.633522

5,866 views
18 citations

Original Research

Published on 19 Apr 2021

Primary Tumor Resection Improves Survival for EGFR-TKI-Treated Patients With Occult M1a Lung Adenocarcinoma

in Thoracic Oncology

Fangqiu Fu
Zhexu Wen
Zhendong Gao
Yue Zhao
Yuan Li
Yang Zhang
Haiquan Chen

Frontiers in Oncology

doi 10.3389/fonc.2021.622723

3,479 views
3 citations

Original Research

Published on 16 Apr 2021

Identifying and Validating Potential Biomarkers of Early Stage Lung Adenocarcinoma Diagnosis and Prognosis

in Thoracic Oncology

Yingji Chen
Longyu Jin
Zhibin Jiang
Suo Liu
Wei Feng

Frontiers in Oncology

doi 10.3389/fonc.2021.644426

5,874 views
25 citations

Original Research

Published on 16 Apr 2021

Pembrolizumab Plus Chemotherapy or Anlotinib vs. Pembrolizumab Alone in Patients With Previously Treated EGFR-Mutant NSCLC

in Thoracic Oncology

Ya Chen
Zhengyu Yang
Yanan Wang
Minjuan Hu
Bo Zhang
Yanwei Zhang
Fangfei Qian
Wei Zhang
Baohui Han

Frontiers in Oncology

doi 10.3389/fonc.2021.671228

7,171 views
28 citations

Original Research

Published on 16 Apr 2021

Comprehensive and Computable Molecular Diagnostic Panel (C2Dx) From Small Volume Specimens for Precision Oncology: Molecular Subtyping of Non-Small Cell Lung Cancer From Fine Needle Aspirates

in Thoracic Oncology

Jing Su
Lynn S. Huang
Ryan Barnard
Graham Parks
James Cappellari
Christina Bellinger
Travis Dotson
Lou Craddock
Bharat Prakash
Jonathan Hovda

Frontiers in Oncology

doi 10.3389/fonc.2021.584896

3,523 views
5 citations

1,972 articles

articles

Driver Genes Associated With the Incidence of Venous Thromboembolism in Patients With Non-Small-Cell Lung Cancer: A Systematic Review and Meta-Analysis

Identification of an Individualized Metabolism Prognostic Signature and Related Therapy Regimens in Early Stage Lung Adenocarcinoma

Pleural Fluid Has Pro-Growth Biological Properties Which Enable Cancer Cell Proliferation

Characteristics of Ground-Glass Nodules Detected by Low-Dose Computed Tomography as a Regular Health Examination Among Chinese Hospital Employees and Their Parents

Cost-Effectiveness Analysis of Atezolizumab Versus Chemotherapy as First-Line Treatment for Metastatic Non-Small-Cell Lung Cancer With Different PD-L1 Expression Status

Comparison of Perioperative Outcomes Between Precise and Routine Segmentectomy for Patients With Early-Stage Lung Cancer Presenting as Ground-Glass Opacities: A Propensity Score-Matched Study

Immune Checkpoint Blockade Therapy May Be a Feasible Option for Primary Pulmonary Lymphoepithelioma-like Carcinoma

Identification of Resectable N2 in NSCLC: A Single Center Experience and Review of the SEER Database

Small Cell Lung Cancer Transformation as a Resistance Mechanism to Osimertinib in Epidermal Growth Factor Receptor-Mutated Lung Adenocarcinoma: Case Report and Literature Review

Identifying Genomic Alterations in Small Cell Lung Cancer Using the Liquid Biopsy of Bronchial Washing Fluid

Combined Analysis of RNA Sequence and Microarray Data Reveals a Competing Endogenous RNA Network as Novel Prognostic Markers in Malignant Pleural Mesothelioma

Nivolumab and Hypofractionated Radiotherapy in Patients With Advanced Lung Cancer: ABSCOPAL-1 Clinical Trial

Molecular Pathology of Pulmonary Large Cell Neuroendocrine Carcinoma: Novel Concepts and Treatments

Commentary: Overall Survival in Heart Disease–Related Death in Non-Small Cell Lung Cancer Patients: Nonimmunotherapy Versus Immunotherapy Era: Population-Based Study

An Immune-Related lncRNA Expression Profile to Improve Prognosis Prediction for Lung Adenocarcinoma: From Bioinformatics to Clinical Word

Development and Validation a Nomogram Incorporating CT Radiomics Signatures and Radiological Features for Differentiating Invasive Adenocarcinoma From Adenocarcinoma In Situ and Minimally Invasive Adenocarcinoma Presenting as Ground-Glass Nodules Measuring 5-10mm in Diameter

Circulating Biomarkers for Early Stage Non-Small Cell Lung Carcinoma Detection: Supplementation to Low‐Dose Computed Tomography

Efficacy, Safety, and Cost-Minimization Analysis of Continuous Infusion of Low-Dose Gemcitabine Plus Cisplatin in Patients With Unresectable Malignant Pleural Mesothelioma

Feasibility and Challenges for Sequential Treatments in ALK-Rearranged Non-Small-Cell Lung Cancer

Efficacy of Combination Chemo-Immunotherapy as a First-Line Treatment for Advanced Non-Small-Cell Lung Cancer Patients With HER2 Alterations: A Case Series

Primary Tumor Resection Improves Survival for EGFR-TKI-Treated Patients With Occult M1a Lung Adenocarcinoma

Identifying and Validating Potential Biomarkers of Early Stage Lung Adenocarcinoma Diagnosis and Prognosis

Pembrolizumab Plus Chemotherapy or Anlotinib vs. Pembrolizumab Alone in Patients With Previously Treated EGFR-Mutant NSCLC

Comprehensive and Computable Molecular Diagnostic Panel (C2Dx) From Small Volume Specimens for Precision Oncology: Molecular Subtyping of Non-Small Cell Lung Cancer From Fine Needle Aspirates